valacyclovir
Generic: valacyclovir
Labeler: bryant ranch prepackDrug Facts
Product Profile
Brand Name
valacyclovir
Generic Name
valacyclovir
Labeler
bryant ranch prepack
Dosage Form
TABLET
Routes
Active Ingredients
valacyclovir hydrochloride 1000 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
71335-2534
Product ID
71335-2534_415566e0-337e-421f-81ae-313f9f33c05c
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA209553
Listing Expiration
2026-12-31
Marketing Start
2023-02-14
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
713352534
Hyphenated Format
71335-2534
Supplemental Identifiers
RxCUI
UNII
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
valacyclovir (source: ndc)
Generic Name
valacyclovir (source: ndc)
Application Number
ANDA209553 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 1000 mg/1
Packaging
- 60 TABLET in 1 BOTTLE (71335-2534-0)
- 30 TABLET in 1 BOTTLE (71335-2534-1)
- 21 TABLET in 1 BOTTLE (71335-2534-2)
- 20 TABLET in 1 BOTTLE (71335-2534-3)
- 4 TABLET in 1 BOTTLE (71335-2534-4)
- 10 TABLET in 1 BOTTLE (71335-2534-5)
- 6 TABLET in 1 BOTTLE (71335-2534-6)
- 15 TABLET in 1 BOTTLE (71335-2534-7)
- 8 TABLET in 1 BOTTLE (71335-2534-8)
- 90 TABLET in 1 BOTTLE (71335-2534-9)
Packages (10)
71335-2534-0
60 TABLET in 1 BOTTLE (71335-2534-0)
71335-2534-1
30 TABLET in 1 BOTTLE (71335-2534-1)
71335-2534-2
21 TABLET in 1 BOTTLE (71335-2534-2)
71335-2534-3
20 TABLET in 1 BOTTLE (71335-2534-3)
71335-2534-4
4 TABLET in 1 BOTTLE (71335-2534-4)
71335-2534-5
10 TABLET in 1 BOTTLE (71335-2534-5)
71335-2534-6
6 TABLET in 1 BOTTLE (71335-2534-6)
71335-2534-7
15 TABLET in 1 BOTTLE (71335-2534-7)
71335-2534-8
8 TABLET in 1 BOTTLE (71335-2534-8)
71335-2534-9
90 TABLET in 1 BOTTLE (71335-2534-9)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "415566e0-337e-421f-81ae-313f9f33c05c", "openfda": {"unii": ["G447S0T1VC"], "rxcui": ["313564"], "spl_set_id": ["b713ebfb-096e-445e-ab15-129aca20fadf"], "manufacturer_name": ["Bryant Ranch Prepack"]}, "finished": true, "packaging": [{"sample": false, "description": "60 TABLET in 1 BOTTLE (71335-2534-0)", "package_ndc": "71335-2534-0", "marketing_start_date": "20241210"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE (71335-2534-1)", "package_ndc": "71335-2534-1", "marketing_start_date": "20241210"}, {"sample": false, "description": "21 TABLET in 1 BOTTLE (71335-2534-2)", "package_ndc": "71335-2534-2", "marketing_start_date": "20241210"}, {"sample": false, "description": "20 TABLET in 1 BOTTLE (71335-2534-3)", "package_ndc": "71335-2534-3", "marketing_start_date": "20241210"}, {"sample": false, "description": "4 TABLET in 1 BOTTLE (71335-2534-4)", "package_ndc": "71335-2534-4", "marketing_start_date": "20241210"}, {"sample": false, "description": "10 TABLET in 1 BOTTLE (71335-2534-5)", "package_ndc": "71335-2534-5", "marketing_start_date": "20241210"}, {"sample": false, "description": "6 TABLET in 1 BOTTLE (71335-2534-6)", "package_ndc": "71335-2534-6", "marketing_start_date": "20241210"}, {"sample": false, "description": "15 TABLET in 1 BOTTLE (71335-2534-7)", "package_ndc": "71335-2534-7", "marketing_start_date": "20241210"}, {"sample": false, "description": "8 TABLET in 1 BOTTLE (71335-2534-8)", "package_ndc": "71335-2534-8", "marketing_start_date": "20241210"}, {"sample": false, "description": "90 TABLET in 1 BOTTLE (71335-2534-9)", "package_ndc": "71335-2534-9", "marketing_start_date": "20241210"}], "brand_name": "Valacyclovir", "product_id": "71335-2534_415566e0-337e-421f-81ae-313f9f33c05c", "dosage_form": "TABLET", "pharm_class": ["DNA Polymerase Inhibitors [MoA]", "Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Nucleoside Analog [EXT]"], "product_ndc": "71335-2534", "generic_name": "Valacyclovir", "labeler_name": "Bryant Ranch Prepack", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Valacyclovir", "active_ingredients": [{"name": "VALACYCLOVIR HYDROCHLORIDE", "strength": "1000 mg/1"}], "application_number": "ANDA209553", "marketing_category": "ANDA", "marketing_start_date": "20230214", "listing_expiration_date": "20261231"}